David Lee: Staying true to our purpose at Servier Pharmaceuticals
David Lee, CEO of Servier Pharmaceuticals, shared a post on LinkedIn:
“When we launched Servier U.S. in 2018, it was with a small but mighty team, one product, and space in a WeWork. What we had in abundance, though, was a steadfast mission: to serve patients who desperately need better treatment options.
We’ve come incredibly far in just 6 years. Together, we’ve turned ambitions into realities, now offering multiple treatment options that have made a meaningful difference in patients’ lives.
This progress reflects the dedication of our team, the collaboration of our partners, and our commitment to leaving no stone unturned in the relentless pursuit of innovation. But our work is far from done.
I’ve shared what’s next for Servier Pharmaceuticals via STAT as we pursue new collaborations, fuel breakthroughs for patients, and stay true to our purpose.
We dare to realize the possibilities.”
More posts featuring David Lee.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023